Pfizer Inc PFE Oncology MA Precedent Signals Sector Upside Amid Eli Lillys Kelonia Acquisition Talks JPM JP Morgan posts 8 percent Q1 2026 EPS beat yet shares dip 109 percent on mixed investor sentiment XTNT Xtant tops Q4 2025 EPS expectations posts 142 percent year over year revenue growth shares rise 7 percent Biogen Inc BIIB Secures Exclusive Global Felzartamab Rights via Greater China Licensing Deal Shares Rally Root ROOT Stock Why New Product Cycle Slow Drop 20260420